Nkarta (Nasdaq: NKTX) will participate in two investor conferences in March 2026: the TD Cowen 46th Annual Health Care Conference on March 2, 2026 and the Leerink Global Healthcare Conference on March 10, 2026.
Each appearance is a fireside chat (9:10 a.m. EST on March 2; 10:40 a.m. EDT on March 10). A simultaneous webcast will be available on the company Investors site, with a replay archived for approximately 90 days.
Loading...
Loading translation...
Positive
None.
Negative
None.
News Market Reaction – NKTX
+3.05%
+3.05%Session close to close
In the Feb 27 session, NKTX gained 3.05%, reflecting a moderate positive market reaction.
This announcement outlines Nkarta’s participation in two March investor conferences, each featuring ...
Analysis
This announcement outlines Nkarta’s participation in two March investor conferences, each featuring a fireside chat and a webcast with 90-day replay access. It primarily enhances investor visibility rather than changing clinical or financial fundamentals. In recent history, similar conference notices have had limited lasting impact compared with earnings and detailed clinical updates. Investors tracking the story may focus on future data readouts and cash runway metrics when assessing the company’s longer-term trajectory.
Announcement of H.C. Wainwright 2025 fireside chat with webcast and 90-day replay.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Conference and presentation announcements have often coincided with flat-to-negative moves, while earnings with clinical updates saw more supportive reactions.
Recent Company History
Over the last six months, Nkarta has repeatedly highlighted investor and scientific visibility alongside clinical and financial updates. Investor conference notices in September, October, and December 2025 were typically neutral but followed by small negative moves. By contrast, Q3 2025 results on Nov 10, 2025 combined a cash balance of $316.5M and NKX019 progress and saw a positive reaction. The ACR Convergence 2025 poster on Oct 26, 2025 shared encouraging NKX019 data yet preceded a notable decline, showing that strong scientific updates have not always translated into near-term share strength.
"a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies"
Natural killer (NK) cell therapies use a type of immune cell that can find and destroy diseased cells — such as cancer — either after being grown and boosted outside the body or after being modified to work better. Investors care because these therapies represent a growing class of targeted treatments with the potential for high clinical benefit and commercial value, but they also carry scientific and regulatory risk similar to other advanced biotechnologies.
Autoimmune diseases are conditions in which the body's immune system mistakenly attacks its own cells, tissues or organs, causing chronic inflammation and damage—think of the immune system as a home security system that wrongly targets the house instead of intruders. Investors care because these illnesses create sustained demand for diagnostics, long-term treatments and specialty drugs, influence regulatory scrutiny and healthcare costs, and can shape the commercial outlook for biotech and pharmaceutical investments.
webcasttechnical
"A simultaneous webcast of both events will be available on the Investors section"
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the following investor conferences:
March 2, 2026 TD Cowen 46th Annual Health Care Conference Boston, MA 9:10 a.m. EST – fireside chat
March 10, 2026 Leerink Global Healthcare Conference Miami, FL 10:40 a.m. EDT – fireside chat
A simultaneous webcast of both events will be available on the Investors section of Nkarta’s website, and a replay will be archived on the website for approximately 90 days.
About Nkarta Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact: Nadir Mahmood Nkarta, Inc. nmahmood@nkartatx.com
FAQ
When will Nkarta (NKTX) present at the TD Cowen conference in March 2026?
Nkarta will present on March 2, 2026 at 9:10 a.m. EST as a fireside chat. According to Nkarta, the event is part of TD Cowen's 46th Annual Health Care Conference and will be webcast simultaneously on the company's Investors website.
What time is Nkarta (NKTX) scheduled to speak at the Leerink Global Healthcare Conference?
Nkarta is scheduled for a fireside chat on March 10, 2026 at 10:40 a.m. EDT. According to Nkarta, the presentation will be webcast live and accessible from the Investors section of the company's website.
How can investors watch Nkarta (NKTX) presentations from the March 2026 conferences?
Investors can watch a simultaneous live webcast via Nkarta's Investors website. According to Nkarta, both events will be webcast live and a replay will be archived on the same site for later viewing.
Will Nkarta (NKTX) provide a replay of its March 2026 conference presentations?
Yes. A replay will be archived on Nkarta's Investors website for approximately 90 days. According to Nkarta, the replay window gives investors time to review the fireside chats after the live webcast ends.
Will Nkarta (NKTX) discuss clinical updates during the March 2026 fireside chats?
The company will present at investor conferences and typically addresses recent developments in such sessions. According to Nkarta, the fireside chats will cover company developments, which may include clinical-stage program updates and strategic priorities.
Where can I find the webcast links and replay for Nkarta (NKTX) March 2026 events?
Webcast links and the replay will be posted on Nkarta's Investors website. According to Nkarta, the simultaneous webcast for both conferences is available on the Investors section and replays are archived there for about 90 days.
